Page last updated: 2024-10-20

pyridoxine and Arterial Occlusive Diseases

pyridoxine has been researched along with Arterial Occlusive Diseases in 6 studies

4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol: structure in first source
vitamin B6 : Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).

Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.

Research Excerpts

ExcerptRelevanceReference
"Treatment with pyridoxine and/or folic acid may lower plasma homocysteine levels."2.68Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease. ( Blom, HJ; Boers, GH; Franken, DG; Jakobs, C; Kluft, C; Rauwerda, JA; Stehouwert, CD; Van den Berg, M; Van Kamp, GJ, 1995)
"Pyridoxilate is a salt formed from glyoxylic acid and pyridoxine."1.27[Calcium oxalate stones and hyperoxaluria secondary to treatment with pyridoxilate]. ( Arvis, G; Barthélémy, C; Maistre-Charransol, G; Steg, A; Thomas, E; Thomas, J; Wolf, C, 1985)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's5 (83.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Van den Berg, M2
Boers, GH2
Franken, DG2
Blom, HJ2
Van Kamp, GJ1
Jakobs, C1
Rauwerda, JA2
Kluft, C1
Stehouwert, CD1
Trijbels, FJ1
Kloppenborg, PW1
de Jong, SC1
Stehouwer, CD1
Geurts, TW1
Bouter, LM1
Weiss, N1
Pietrzik, K1
Keller, C1
Brattström, L1
Israelsson, B1
Norrving, B1
Bergqvist, D1
Thörne, J1
Hultberg, B1
Hamfelt, A1
Wolf, C1
Maistre-Charransol, G1
Barthélémy, C1
Thomas, E1
Thomas, J1
Arvis, G1
Steg, A1

Reviews

2 reviews available for pyridoxine and Arterial Occlusive Diseases

ArticleYear
[Hyperhomocysteinemia, a risk factor for atherosclerosis: causes and effects].
    Deutsche medizinische Wochenschrift (1946), 1999, Sep-24, Volume: 124, Issue:38

    Topics: Age Factors; Arterial Occlusive Diseases; Arteriosclerosis; Cerebrovascular Disorders; Coronary Dise

1999
Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment.
    Atherosclerosis, 1990, Volume: 81, Issue:1

    Topics: Adult; Arterial Occlusive Diseases; Cerebral Arterial Diseases; Cystathionine beta-Synthase; Female;

1990

Trials

1 trial available for pyridoxine and Arterial Occlusive Diseases

ArticleYear
Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease.
    European journal of clinical investigation, 1995, Volume: 25, Issue:3

    Topics: Adult; Amino Acid Metabolism, Inborn Errors; Arterial Occlusive Diseases; Biomarkers; Blood Pressure

1995

Other Studies

3 other studies available for pyridoxine and Arterial Occlusive Diseases

ArticleYear
Treatment of mild hyperhomocysteinemia in vascular disease patients.
    Arteriosclerosis and thrombosis : a journal of vascular biology, 1994, Volume: 14, Issue:3

    Topics: Adult; Arterial Occlusive Diseases; Female; Homocysteine; Humans; Male; Middle Aged; Pyridoxine

1994
Normohomocysteinaemia and vitamin-treated hyperhomocysteinaemia are associated with similar risks of cardiovascular events in patients with premature peripheral arterial occlusive disease. A prospective cohort study.
    Journal of internal medicine, 1999, Volume: 246, Issue:1

    Topics: Adult; Age of Onset; Aged; Arterial Occlusive Diseases; Cardiovascular Diseases; Female; Folic Acid;

1999
[Calcium oxalate stones and hyperoxaluria secondary to treatment with pyridoxilate].
    Annales d'urologie, 1985, Volume: 19, Issue:5

    Topics: Aged; Animals; Arterial Occlusive Diseases; Calcium Oxalate; Female; Humans; Kidney Calculi; Male; M

1985